Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Carcinoma, Hepatocellular 8Triple Negative Breast Neoplasms 7Nasopharyngeal Carcinoma 7Breast Neoplasms 6Esophageal Neoplasms 4Colorectal Neoplasms 4Uterine Cervical Neoplasms 3Stomach Neoplasms 3Squamous Cell Carcinoma of Head and Neck 3Pancreatic Neoplasms 3Liver Neoplasms 3Neoplasm Metastasis 2Locally Advanced Rectal Cancer 2Carcinoma, Non-Small-Cell Lung 2Adrenocortical Carcinoma 2Unresectable Gallbladder Cancer 1Turcot syndrome 1Sarcoma 1Salivary Gland Neoplasms 1Recurrence 1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1Osteosarcoma 1Non Squamous Non Small Cell Lung Cancer 1Nasopharyngeal Neoplasms 1Multiple Primary Lung Cancer 1Melanoma 1Locally Advanced or Metastatic Solid Tumors 1Liver Diseases 1Leukemia, Myeloid, Acute 1Her-2 Negative Breast Cancer 1

Interventions

Trastuzumab 3trastuzumab deruxtecan 2sacituzumab govitecan 2pertuzumab 2pembrolizumab 2Magnetic Resonance Spectroscopy 2Goserelin 2Carboplatin 2Biopsy 2Ado-Trastuzumab Emtansine 2zanidatamab 1trastuzumab biosimilar HLX02 1spartalizumab 1pyrotinib 1enfortumab vedotin 1camrelizumab 1bicalutamide 1apatinib 1abiraterone 1Tablets 1Specimen Handling 1Radiation 1Poly(ADP-ribose) Polymerase Inhibitors 1Platinum 1PF-05280014 1Ontruzant 1Ogivri 1Observation 1Maytansine 1Leuprolide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Salivary Gland Neoplasms × camrelizumab × Clear all
NCT06145308 2026-04-02

Precision Treatment of Recurrent/Metastatic Salivary Gland Carcinoma Guided by Molecular Typing

Peking Union Medical College

Phase 2 Recruiting
39 enrolled
Head & Neck

Salivary Gland Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡